Bladder Cancer Prognosis By Stage
by admin on Saturday, July 31st, 2010 | No Comments
Scientists safeguard announces second quarter 2010 Financial Results WAYNE, Pa. – (BUSINESS WIRE) – Safeguard Scientifics Announces Second Quarter 2010 Financial, 2010 The company's total revenue associated with the further guidance is expected to be between $ 325 million and U.S. $ 350 million
Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive Bladder Cancer